<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03654209</url>
  </required_header>
  <id_info>
    <org_study_id>1805411306</org_study_id>
    <nct_id>NCT03654209</nct_id>
  </id_info>
  <brief_title>Post-resection Treatment of Large Colon Polyps</brief_title>
  <acronym>SAP</acronym>
  <official_title>Prospective Randomized Controlled Trial Describing the Recurrence Rate of Adenomas in Sessile or Flat Colonic Lesions 15mm or Larger Receiving Post-resection Site Treatment With Snare Tip Soft Coagulation or Argon Plasma Coagulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AdventHealth Orlando</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Mount Sinai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NYU Langone Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who have provided informed consented and are scheduled to undergo endoscopic mucosal
      resection (EMR) of lesions 15mm and larger will be randomized to STSC (80 W, Effect 5) vs APC
      (preferred settings) vs No Treatment of the perimeter of the EMR site.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data regarding polyp morphology, location &amp; shape will be recorded in addition to procedure
      and treatment length. Injection fluid use and clipping will also be recorded in addition to
      any procedural complications.

      All randomized subjects will receive a 30-day post procedure follow-up phone call and be
      scheduled, as per the standard of care, to receive a standard follow-up colonoscopy procedure
      approximately 6 months from the initial procedure. The investigators will measure the rate of
      recurrence by endoscopic visualization of the EMR site at the 6 month follow-up using
      endoscopic magnification and electronic chromoendoscopy, as well as systematic biopsy of the
      scars.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2018</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to Argon Plasma Coagulation vs Snare Tip Soft Coagulation vs no treatment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>1 day</time_frame>
    <description>The recurrence rate of adenomas at the site of any qualifying, previously resected lesions will be measured at the 6 month follow-up colonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time</measure>
    <time_frame>1 day</time_frame>
    <description>The time it takes to apply each respective treatment (APC or STSC) on the day of procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 day</time_frame>
    <description>To look at the number of complications for each randomization arm as assessed through a 30 day follow-up phone call</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis</measure>
    <time_frame>1 day</time_frame>
    <description>Cost analysis detailing the effectiveness of the treatment versus the cost of each therapeutic device (argon probe vs. snare)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Recurrence</condition>
  <arm_group>
    <arm_group_label>Argon Plasma Coagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following polyp removal using standard of care methods, Argon Plasma Coagulation (APC) will be applied to the perimeter of the resection site before any clips are added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Snare Tip Soft Coagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following polyp removal using standard of care methods, Snare Tip Soft Coagulation (STSC) will be applied to the perimeter of the resection site before any clips are added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Following polyp removal using standard of care methods, neither APC nor STSC will be applied to the perimeter of the resection site. Clips may be added at the discretion of the PI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Argon Plasma Coagulation</intervention_name>
    <description>APC will be applied to the perimeter of the resection site</description>
    <arm_group_label>Argon Plasma Coagulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Snare Tip Soft Coagulation</intervention_name>
    <description>STSC will be applied to the perimeter of the resection site</description>
    <arm_group_label>Snare Tip Soft Coagulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  25 years and older

          -  Ability to provide informed consent

          -  Undergoing colonoscopy for screening, surveillance, diagnostic reasons, or removal of
             a lesion

        Exclusion Criteria:

          -  Pedunculated lesions

          -  Inflammatory bowel disease

          -  Inability to provide informed consent

          -  Lesions less than 15mm in largest dimension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas K. Rex, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Broadley, MA</last_name>
    <phone>317-278-4554</phone>
    <email>hbroadle@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonathan Garcia, BS</last_name>
    <phone>317-948-0117</phone>
    <email>garciajr@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University Health University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dougls K Rex</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Springmill medical center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Douglas K Rex</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>December 20, 2019</last_update_submitted>
  <last_update_submitted_qc>December 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Douglas K. Rex</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Argon Plasma Coagulation</keyword>
  <keyword>Snare Tip Soft Coagulation</keyword>
  <keyword>Recurrence rates</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Individual participant data will only be available to study team members who are approved by the Institutional Review Board. All paper charts pertaining to the patient will be kept under lock and key in the coordinator's office away from the endoscopy area. Data will be entered into an excel file which will be stored on an internal network drive with encryption and password security. Data management will include double data entry and regular back-up of the data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

